Sundquist M, Thorstenson S, Brudin L, Stål O, Nordenskjöld B
Department of Surgery, County Hospital, Kalmar, Sweden.
Breast Cancer Res Treat. 2000 Sep;63(1):11-5. doi: 10.1023/a:1006494625644.
Flow cytometric DNA analysis with assessment of S-phase fraction and DNA ploidy was compared to Nottingham histologic grade. The study population consisted of 654 patients who presented between 1987 and 1996 with primary operable breast cancer and whose tumours had been analysed for S-phase fraction and DNA ploidy at the time of surgery. Grade, tumour size, node status, steroid receptor status, age, S-phase fraction and DNA ploidy were analysed univariately and multi-variately in a Cox proportional hazard analysis. In the univariate analyses all parameters were statistically significantly associated with breast cancer mortality during the follow-up period of 2-11 years. The most powerful predictor of death from breast cancer in the multiple regression analysis was grade. Patients with grade 1 tumours have excellent prognosis. We conclude that tumour grade is a strong prognostic indicator applicable to all breast cancer patients, regardless of size and nodal status, and advocate its general use.
将流式细胞术DNA分析与S期分数评估和DNA倍性评估与诺丁汉组织学分级进行了比较。研究人群包括654例在1987年至1996年间患有原发性可手术乳腺癌的患者,其肿瘤在手术时已进行S期分数和DNA倍性分析。在Cox比例风险分析中,对分级、肿瘤大小、淋巴结状态、类固醇受体状态、年龄、S期分数和DNA倍性进行了单变量和多变量分析。在单变量分析中,所有参数在2至11年的随访期内均与乳腺癌死亡率有统计学显著关联。多元回归分析中,乳腺癌死亡的最有力预测因素是分级。1级肿瘤患者预后良好。我们得出结论,肿瘤分级是一个强大的预后指标,适用于所有乳腺癌患者,无论肿瘤大小和淋巴结状态如何,并提倡广泛使用。